A detailed history of Susquehanna International Group, LLP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 8,000 shares of XENE stock, worth $306,480. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,000
Previous 23,036 65.27%
Holding current value
$306,480
Previous $898,000 65.03%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$36.25 - $43.75 $22,112 - $26,687
-610 Reduced 2.58%
23,036 $898,000
Q1 2024

May 07, 2024

SELL
$42.66 - $50.04 $1.25 Million - $1.47 Million
-29,305 Reduced 55.34%
23,646 $1.02 Million
Q4 2023

Feb 14, 2024

BUY
$28.7 - $46.46 $1.52 Million - $2.46 Million
52,951 New
52,951 $2.44 Million
Q2 2023

Aug 11, 2023

SELL
$34.84 - $43.54 $259,139 - $323,850
-7,438 Reduced 47.77%
8,131 $313,000
Q1 2023

May 16, 2023

BUY
$33.46 - $40.35 $520,938 - $628,209
15,569 New
15,569 $557,000
Q2 2022

Aug 15, 2022

BUY
$25.44 - $35.16 $361,197 - $499,201
14,198 Added 70.32%
34,389 $1.05 Million
Q1 2022

May 16, 2022

SELL
$25.09 - $33.13 $152,747 - $201,695
-6,088 Reduced 23.17%
20,191 $617,000
Q3 2021

Nov 15, 2021

SELL
$14.86 - $19.45 $381,931 - $499,903
-25,702 Reduced 49.44%
26,279 $402,000
Q2 2021

Aug 11, 2021

BUY
$16.81 - $20.0 $437,043 - $519,980
25,999 Added 100.07%
51,981 $968,000
Q1 2021

May 17, 2021

BUY
$13.65 - $21.31 $354,654 - $553,676
25,982 New
25,982 $465,000

Others Institutions Holding XENE

About Xenon Pharmaceuticals Inc.


  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.39B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.